Cardiology's gains are far less than some specialties—pay for dermatologists went up more than 10%, for instance—but still ahead of the consumer price index.

This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value. 

According to a new proposal, using AI to evaluate CCTA results and quantify plaque buildup is “reasonable and medically necessary” in certain clinical scenarios.

The deal, first announced in April, has been finalized. Shockwave will now operate as a business unit within Johnson & Johnson MedTech, and its common stock is no longer trading on NASDAQ.

HRS President Kenneth Ellenbogen, MD, detailed some of the biggest trends in electrophysiology at Heart Rhythm 2024 in Boston. 

The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care. 

Professor Om Shankar, who lost his hospital leadership position as a result of the strike, is now forming a committee with like-minded protesters to “spread the agitation all across the country.”

Researchers explored five-year data from more than 1,300 TAVR patients treated with a balloon-expandable Sapien 3 valve, sharing their findings at New York Valves 2024: The Structural Heart Summit.

Researchers explored decades of data from more than 25,000 women, sharing their findings in JAMA Network Open.

Researchers developed an advanced AI model capable of extracting measurements from unprocessed CT images in seconds. It then uses those data to evaluate the patient's mortality risk if they underwent TAVR.